"Lexington Medical Center is a 485-bed hospital in West Columbia, South Carolina. It anchors a health care network that includes five community medical centers and employs a staff of more than 6,500 health care professionals."

During the past decade, Lexington Medical Center conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 23 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lexington Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Boston Scientific Corporation" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lexington Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Lexington Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Breast Cancer" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (5 trials) and "Estrogen Receptor Negative" (3 trials). Many other conditions were trialed in "Lexington Medical Center" in a lesser frequency.

Most popular intervention types in "Lexington Medical Center" are "Other" (35 trials), "Drug" (31 trials), "Biological" (17 trials), "Device" (13 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (10 trials), "Paclitaxel" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Lexington Medical Center" are 46 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lexington Medical Center". undefined are not yet recruiting, 10 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Lexington Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lexington Medical Center, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".

Lexington Medical Center has several departments that took part in Clinical trials: "Lexington Cardiology" - 4 trials